Please login to the form below

Not currently logged in
Email:
Password:

Former AstraZeneca man Graham Walker joins Idea Pharma

Will work with product teams to bridge gap between clinical and commercial

Graham Walker - IDEA PharmaDr Graham Walker has joined product design consultants Idea Pharma as a member of its Ideation team.

He will work alongside global product teams to form strategies for compounds in phase II development in an attempt to link more closely the clinical and commercial stages of a drug's lifespan.

Dr Walker's previous experience in the field includes two years at AstraZeneca between 2009 and 2010 where he served as therapy area physician - oncology.

During his time at the pharma company he was part of the team that helped bring the non small cell lung cancer (NSCLC) drug Iressa (gefitinib) to market.

Dr Walker later left AZ to join Napp Pharmacueuticals in the UK where he worked on the company's respiratory products.

Prior to his career in the industry, Dr Walker served in the clinical environment at several UK hospitals.

He was also director of his own technology company, HealthTrade, from 2001 to 2008, which used the latest technological advancements to provide healthcare solutions.

“My career to date has been built on spearheading innovation within many commercial organisations,” said Dr Walker, “so it makes complete sense to join Idea, a company that is clearly leading the industry in ensuring innovative drugs get to market in great shape. I look forward to tackling the challenges that lie ahead.”

Mike Rea, Idea's CEO, commented: “We were really lucky to find Graham. He was about to accept a great position with one of the 'top 5' when we met.”

14th May 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Digitas Health

Digitas Health is the only digital-at-the-core brand agency designed to connect today's healthcare brands with today's healthcare consumers and professionals....

Latest intelligence

EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
Peoples Award
Quality in Care Diabetes 2018: the best in innovative diabetes care
Awards highlight new evidence-based approaches to improving care...

Infographics